Online citations, reference lists, and bibliographies.
← Back to Search

Development Of Cephalexin-loaded Poly(ethyl Cyanoacrylate) Colloidal Nanospheres

G. Yordanov
Published 2012 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
AbstractThis article considers the preparation and physicochemical characterization of a novel colloidal formulation of the β-lactam antibiotic cephalexin, loaded in poly(ethyl cyanoacrylate) colloidal nanospheres. The drug was loaded by means of drug incorporation in the interior of poly(ethyl cyanoacrylate) particles during the polymerization of the respective monomer in aqueous medium. The obtained colloids were characterized by scanning electron microscopy, dynamic and electrophoretic light scattering, Fourier transform infrared and nuclear magnetic resonance spectroscopy. It was found that the drug loading efficiency depends on the initial concentration of monomer and cephalexin in the polymerization medium. The average size of cephalexin-loaded particles was around 400 nm and did not depend significantly on the concentrations of drug and monomer. Drug-loaded particles with drug content as high as 21% (w/w) were prepared. The drug release kinetics was studied in physiological phosphate-buffered saline. It was found that a biexponential model could describe well the experimental release kinetics.
This paper references
10.1016/S0142-9612(00)00286-6
Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation.
N. Behan (2001)
10.1016/S0939-6411(99)00076-4
Allopurinol encapsulated in polycyanoacrylate nanoparticles as potential lysosomatropic carrier: preparation and trypanocidal activity.
G. González-Martín (2000)
10.1016/J.POLYMDEGRADSTAB.2008.04.012
Synthesis and degradation behavior of poly(ethyl cyanoacrylate)
M. G. Han (2008)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1007/BF01964420
Intracellular distribution and activity of antibiotics
P. Tulkens (2005)
10.1002/JPS.2600521210
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.
T. Higuchi (1963)
10.1016/S0376-7388(00)83223-8
Analysis of non-fickian transport in polymers using simplified exponential expressions
G. Sinclair (1984)
10.1016/S0168-3659(01)00519-3
Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core.
J. L. Arias (2001)
10.1016/0378-5173(89)90274-3
Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles
J. Kreuter (1989)
10.1016/0378-5173(90)90280-H
Drug release from microdisperse systems: a critical review
C. Washington (1990)
10.1016/0378-5173(92)90210-S
Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
C. Lherm (1992)
10.1016/0142-9612(90)90084-4
In vitro model for the degradation of alkylcyanoacrylate nanoparticles.
R. H. Müller (1990)
10.1128/AAC.33.9.1540
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.
E. Fattal (1989)
10.1016/S0924-8579(99)00121-1
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
H. Pinto-Alphandary (2000)
10.1016/S0378-5173(98)00116-1
Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: pharmacokinetics and in vitro antimicrobial activity
F. Fawaz (1998)
10.1002/WICS.48
Wiley Interdisciplinary Reviews
F. Jensen (2009)
10.1093/JAC/37.1.105
Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles.
O. Balland (1996)
10.1128/AEM.15.4.765-769.1967
Cephalexin, a new orally absorbed cephalosporin antibiotic.
W. E. Wick (1967)
10.1016/J.IJPHARM.2007.05.062
Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.
K. Kisich (2007)
10.1016/0378-5173(94)90399-9
Entrapment of β-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system
G. Cavallaro (1994)
10.1016/S0142-9612(01)00030-8
Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
G. Fontana (2001)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1016/j.ijpharm.2009.04.045
Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
Li-Ching Chang (2009)
10.1016/S0378-5173(97)00395-5
Increase in gentamicin uptake by cultured mouse peritoneal macrophages and rat hepatocytes by its binding to polybutylcyanoacrylate nanoparticles
Qiang Zhang (1998)
10.1016/J.JCONREL.2007.09.008
Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles.
J. L. Arias (2008)
10.1016/0378-5173(91)90128-B
Approaches to improve the association of amikacin sulphate to poly(alkylcyanoacrylate) nanoparticles
M. Alonso (1991)
10.1016/J.JCONREL.2007.10.027
Delivery systems to increase the selectivity of antibiotics in phagocytic cells.
E. Briones (2008)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1002/wnan.15
Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
J. Nicolas (2009)
10.1007/S00396-010-2219-5
Preparation and physicochemical characterization of novel chlorambucil-loaded nanoparticles of poly(butylcyanoacrylate)
G. Yordanov (2010)
Controlled Release of Biologically Active Agents
R. W. Baker (1987)
10.1186/1477-3155-2-3
Applications of nanoparticles in biology and medicine
OV Salata (2004)
10.1007/s000180300002
Colloidal drug carriers: achievements and perspectives
G. Barratt (2003)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar